Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 2,614,224 |
|
|||||
| News | - | ||||||
| Day High | 1.55 | Low High |
|||||
| Day Low | 1.30 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Veru Inc | VERU | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.14 | -9.86% | 1.28 | 19:54:37 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.39 | 1.30 | 1.55 | 1.31 | 1.42 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,092 | 2,614,224 | $ 1.40 | $ 3,656,070 | - | 0.36 - 1.92 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:54:36 | formt | 109 | $ 1.28 | USD |
Veru Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 191.76M | 146.38M | - | 16.3M | -93.09M | -0.64 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Veru News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VERU Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.81 | 1.85 | 1.00 | 1.43 | 5,175,273 | -0.53 | -29.28% |
| 1 Month | 0.565 | 1.92 | 0.55 | 1.29 | 4,007,526 | 0.715 | 126.55% |
| 3 Months | 0.4537 | 1.92 | 0.3612 | 0.9327837 | 2,424,610 | 0.8263 | 182.12% |
| 6 Months | 0.9266 | 1.92 | 0.36 | 0.8382392 | 1,908,030 | 0.3534 | 38.14% |
| 1 Year | 1.01 | 1.92 | 0.36 | 0.9660667 | 1,658,829 | 0.27 | 26.73% |
| 3 Years | 9.45 | 24.55 | 0.36 | 10.42 | 4,383,371 | -8.17 | -86.46% |
| 5 Years | 1.44 | 24.56 | 0.36 | 10.25 | 3,239,708 | -0.16 | -11.11% |
Veru Description
| Veru Inc is a biopharmaceutical company focused on urology and oncology. It develops prescription products for benign prostatic hyperplasia hot flashes associated with cancer treatment, male infertility, and novel chemotherapies for a variety of cancers. The company currently operates in two reporting segments: Sexual health business and Research & development. Some of its products include Zuclomiphene, Veru-111, Veru-100, FC2, and Roman Swipes. The company generates the majority of its revenue from the United States. |
